Pliant Therapeutics (PLRX)

• Market cap: $79.9M
• 1 day: -4.62%
• 5 days: 8.77%
• 1 month: -3.13%
• 3 months: -20.51%
• 6 months: -13.29%
• Year to date: -0.8%
• 1 year: -58.8%
• 5 years: -96.45%
• 10 years: -94.18%
• Sector: Healthcare
• Industry: Biotechnology

About: Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Employees: 171